Product Code: RP-ID-10326637 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10326637
Market Overview:
Global Wound Debridement Market Size study with COVID-19 impact, by Product (Hydro Surgical Debridement Devices, Low-Frequency Ultrasound Devices, Surgical Wound Debridement Devices, Mechanical Debridement Pads, Traditional Wound Debridement Devices and Larval Therapy), by Application (Chronic Ulcers, Surgical Wounds, Traumatic Wounds and Burn Cases), by End-User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Nursing Facilities and Others) and Regional Forecasts 2020-2027
Global Wound Debridement Market is valued approximately USD 766.79 Million in 2019 and is anticipated to grow with a healthy growth rate of more than 7.20% over the forecast period 2020-2027. Wound debridement defined to the technique of elimination of useless, contaminated, and dangerous tissue from a wound to promote wound recovery. The wound debridement can be finished by means of chemical, enzymatic, surgical, mechanical, and autolytic way (herbal strategies) to cast off the undesirable tissue. The dead skin hinders the formation of new tissue and hides the signs of infections if any present, as a result makes it tough for remedy. In addition, the wound debridement products help lessen diverse varieties of microbes, pollutants, and other foreign cloth that inhibit restoration of the wound, which facilitates heal fast. The global spread of COVID-19 favorably supports the growth of wound debridement market. The global pandemic of COVID-19 leads to the shortage of essential treatment tools in healthcare centers and hospitals which stimulated the large demand of healthcare and medical instruments. Therefore, such initiatives will be significantly impacting in optimum care, create of effective infrastructure and manufacturing of various testing kits for infected peoples which will propel the growth of market over the forecast years. In addition, growing geriatric population and incidence of diabetes & associated wounds is anticipated to drive the growth of market to offer effective treatment to patients. For instance: According to the World Health Organization, the number of people aged 65 or older is projected to grow from an estimated 524 million in 2010 to nearly 1.6 billion in 2050, with most of the increase in developing countries. Also, as per diabetes research & clinical practice, the global diabetes prevalence in 2019 is estimated to be 9.3% (463 million people), rising to 10.2% (578 million) by 2030 and 10.9% (700 million) by 2045. However, high cost of enzymatic debridement and surgical devices is the factor hampering the market growth over the forecast years.
The regional analysis of global Wound Debridement Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing prevalence of diabetes, high penetration of enzymatic debridement products, and strong market player presence. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as presence of a large patient population and increasing awareness regarding advanced healthcare products would create lucrative growth prospects for the Wound Debridement Market across Asia-Pacific region.
Major market player included in this report are:
Coloplast
ConvaTec
Medline Industries, Inc.
Smith & Nephew
Mölnlycke Health Care AB.
B. Braun Melsungen AG
Paul Hartmann AG
Acelity L.P., Inc.
Lohmann & Rauscher International Gmbh & Co Kg
Integra Lifesciences.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Hydro Surgical Debridement Devices
Low-Frequency Ultrasound Devices
Surgical Wound Debridement Devices
Mechanical Debridement Pads
Traditional Wound Debridement Devices
Larval Therapy
By Application:
Chronic Ulcers
Surgical Wounds
Traumatic Wounds
Burn Cases
By End-User:
Hospitals
Ambulatory Surgical Centers
Specialized Clinics
Nursing Facilities
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Wound Debridement Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Coloplast
ConvaTec
Medline Industries, Inc.
Smith & Nephew
Mölnlycke Health Care AB.
B. Braun Melsungen AG
Paul Hartmann AG
Acelity L.P., Inc.
Lohmann & Rauscher International Gmbh & Co Kg
Integra Lifesciences.
Related Reports
Proof of Quality & Reliability
